A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies
Enrolling by invitation
Conditions studied: Hematologic Malignancy, Solid Malignancy
In brief
This study will evaluate the long-term safety and efficacy of CRISPR CAR T cellular therapies
Key facts
- Study ID
- NCT06208878
- Run by
- CRISPR Therapeutics AG
- People needed
- 70
- Starts
- 2023-11-22
- Expected to finish
- 2038-08-01
- Last updated by the study team
- 2025-08-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Able to understand and comply with protocol-required study procedures and voluntarily sign and date a written informed consent document.
- Must have received CRISPR CAR T cellular therapy.
You may not qualify if…
- There are no specific exclusion criteria.
Where it is running
- Cedars Sinai — Los Angeles, California, United States
- Stanford — Stanford, California, United States
- Yale New Haven Hospital — New Haven, Connecticut, United States
- Emory — Atlanta, Georgia, United States
- University of Chicago — Chicago, Illinois, United States
- University of Kansas — Westwood, Kansas, United States
- University of Minnesota — Minneapolis, Minnesota, United States
- Washington University Saint Louis — St Louis, Missouri, United States
- MSKCC — New York, New York, United States
- Montefiore Medical Center — The Bronx, New York, United States
- Oregon Health and Science University — Portland, Oregon, United States
- University of Pennsylvania — Philadelphia, Pennsylvania, United States
- UT Southwestern — Dallas, Texas, United States
- MD Anderson Cancer Center — Houston, Texas, United States
- Methodist Hospital-Sarah Cannon — San Antonio, Texas, United States
- University of Utah-Huntsman Cancer Institute — Salt Lake City, Utah, United States
- Royal Prince Alfred Hospital — Camperdown, New South Wales, Australia
- Peter MacCallum Cancer Center — Melbourne, Victoria, Australia
- Sir Charles Gairdner — Nedlands, Australia
- Princess Margaret — Toronto, Ontario, Canada
- University Hospital Hamburg-Eppendorf — Hamburg, Germany
- City of Hope — Duarte, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.